328 related articles for article (PubMed ID: 34327215)
21. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma.
Wang G; Liu P; Li J; Jin K; Zheng X; Xie L
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891325
[TBL] [Abstract][Full Text] [Related]
22. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X
Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630
[TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.
Hua S; Xie Z; Wang W; Wan Z; Chen M; Zhao S; Jiang J
Front Oncol; 2021; 11():704946. PubMed ID: 34322391
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
[No Abstract] [Full Text] [Related]
25. Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma.
Zhu Y; Shan D; Guo L; Chen S; Li X
Int J Gen Med; 2022; 15():1919-1931. PubMed ID: 35237066
[TBL] [Abstract][Full Text] [Related]
26. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
27. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
Jing L; Du Y; Fu D
Front Genet; 2022; 13():979575. PubMed ID: 36105083
[TBL] [Abstract][Full Text] [Related]
28. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
Front Genet; 2022; 13():1085700. PubMed ID: 36579330
[No Abstract] [Full Text] [Related]
29. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
30. Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Zhu C; Wu Q; Yang N; Zheng Z; Zhou F; Zhou Y
Front Genet; 2022; 13():848841. PubMed ID: 35586567
[No Abstract] [Full Text] [Related]
31. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
32. An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer.
Jiang H; Sun J; Liu F; Wu X; Wen Z
Front Genet; 2022; 13():895200. PubMed ID: 35812755
[No Abstract] [Full Text] [Related]
33. A senescence-related lncRNA signature predicts prognosis and reflects immune landscape in HNSCC.
Chen L; Lin J; Wen Y; Lan B; Xiong J; Fu Y; Chen Y; Chen CB
Oral Oncol; 2024 Feb; 149():106659. PubMed ID: 38134702
[TBL] [Abstract][Full Text] [Related]
34. A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients.
Jiang H; Ma B; Xu W; Luo Y; Wang X; Wen S; Liao T; Lu Z; Yang S; Wang Y
Ann Surg Oncol; 2021 Jun; 28(6):3396-3406. PubMed ID: 33095358
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
[TBL] [Abstract][Full Text] [Related]
36. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
37. Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma.
Wu C; Liu F; Chen H; Liu Q; Song C; Cheng K; Gao Z; Fan C
J Oncol; 2022; 2022():7602482. PubMed ID: 35909900
[TBL] [Abstract][Full Text] [Related]
38. Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Diao P; Song Y; Ge H; Wu Y; Li J; Zhang W; Wang Y; Cheng J
J Cell Biochem; 2019 Jun; 120(6):10010-10020. PubMed ID: 30548328
[TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes.
Feng C; Liu S; Shang Z
Front Cell Dev Biol; 2021; 9():798898. PubMed ID: 35273966
[TBL] [Abstract][Full Text] [Related]
40. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]